Otsuka Holdings Co Ltd ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $17.93
- Today's High:
- $19.01
- Open Price:
- $19.01
- 52W Low:
- $14.42
- 52W High:
- $20.31
- Prev. Close:
- $18.2
- Volume:
- 42628
Company Statistics
- Market Cap.:
- $19.75 billion
- Book Value:
- 2236.1836
- Revenue TTM:
- $1,871.23 billion
- Operating Margin TTM:
- 12.28%
- Gross Profit TTM:
- $1,168.50 billion
- Profit Margin:
- 8.92%
- Return on Assets TTM:
- 4.48%
- Return on Equity TTM:
- 7.23%
Company Profile
Otsuka Holdings Co Ltd ADR had its IPO on under the ticker symbol OTSKY.
The company operates in the Healthcare sector and Drug Manufacturers-General industry. Otsuka Holdings Co Ltd ADR has a staff strength of 33,482 employees.
Stock update
Shares of Otsuka Holdings Co Ltd ADR opened at $19.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $17.93 - $19.01, and closed at $18.5.
This is a +1.65% increase from the previous day's closing price.
A total volume of 42,628 shares were traded at the close of the day’s session.
In the last one week, shares of Otsuka Holdings Co Ltd ADR have slipped by -2.06%.
Otsuka Holdings Co Ltd ADR's Key Ratios
Otsuka Holdings Co Ltd ADR has a market cap of $19.75 billion, indicating a price to book ratio of 1.1021 and a price to sales ratio of 0.0109.
In the last 12-months Otsuka Holdings Co Ltd ADR’s revenue was $1,871.23 billion with a gross profit of $1,168.50 billion and an EBITDA of $324.40 billion. The EBITDA ratio measures Otsuka Holdings Co Ltd ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Otsuka Holdings Co Ltd ADR’s operating margin was 12.28% while its return on assets stood at 4.48% with a return of equity of 7.23%.
In Q2, Otsuka Holdings Co Ltd ADR’s quarterly earnings growth was a negative -11.4% while revenue growth was a positive 15%.
Otsuka Holdings Co Ltd ADR’s PE and PEG Ratio
- Forward PE
- 15.3374
- Trailing PE
- 17.5
- PEG
- 0
Its diluted EPS in the last 12-months stands at $1.04 per share while it has a forward price to earnings multiple of 15.3374 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Otsuka Holdings Co Ltd ADR’s profitability.
Otsuka Holdings Co Ltd ADR stock is trading at a EV to sales ratio of 0.0097 and a EV to EBITDA ratio of 0.0667. Its price to sales ratio in the trailing 12-months stood at 0.0109.
Otsuka Holdings Co Ltd ADR stock pays annual dividends of $100 per share, indicating a yield of 1.96% and a payout ratio of 31.9%.
Balance sheet and cash flow metrics
- Total Assets
- $3,308.78 billion
- Total Liabilities
- $580.92 billion
- Operating Cash Flow
- $0
- Capital Expenditure
- $24.13 billion
- Dividend Payout Ratio
- 31.9%
Otsuka Holdings Co Ltd ADR ended 2024 with $3,308.78 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3,308.78 billion while shareholder equity stood at $2,427.09 billion.
Otsuka Holdings Co Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $580.92 billion in other current liabilities, 81690000000.00 in common stock, $1,628.42 billion in retained earnings and $353.25 billion in goodwill. Its cash balance stood at $498.66 billion and cash and short-term investments were $519.76 billion. The company’s total short-term debt was $60,570,000,000 while long-term debt stood at $71.75 billion.
Otsuka Holdings Co Ltd ADR’s total current assets stands at $1,274.46 billion while long-term investments were $0 and short-term investments were $21.10 billion. Its net receivables were $442.29 billion compared to accounts payable of $174.22 billion and inventory worth $250.92 billion.
In 2024, Otsuka Holdings Co Ltd ADR's operating cash flow was $0 while its capital expenditure stood at $24.13 billion.
Comparatively, Otsuka Holdings Co Ltd ADR paid $0.32 in dividends in 2024.
Other key metrics
- Current Trading Price
- $18.5
- 52-Week High
- $20.31
- 52-Week Low
- $14.42
- Analyst Target Price
- $
Otsuka Holdings Co Ltd ADR stock is currently trading at $18.5 per share. It touched a 52-week high of $20.31 and a 52-week low of $20.31. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $18.67 and 200-day moving average was $17.16 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 31.9% are held by institutions.
Frequently Asked Questions About Otsuka Holdings Co Ltd ADR
Similar Industry Stocks (Drug Manufacturers-General)
Most Active
Top Gainers
Top Losers
About
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women’s health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.